1. Home
  2. CRBU vs BVFL Comparison

CRBU vs BVFL Comparison

Compare CRBU & BVFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • BVFL
  • Stock Information
  • Founded
  • CRBU 2011
  • BVFL 1873
  • Country
  • CRBU United States
  • BVFL United States
  • Employees
  • CRBU N/A
  • BVFL N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • BVFL Savings Institutions
  • Sector
  • CRBU Health Care
  • BVFL Finance
  • Exchange
  • CRBU Nasdaq
  • BVFL Nasdaq
  • Market Cap
  • CRBU 179.7M
  • BVFL 163.3M
  • IPO Year
  • CRBU 2021
  • BVFL N/A
  • Fundamental
  • Price
  • CRBU $2.68
  • BVFL $15.40
  • Analyst Decision
  • CRBU Strong Buy
  • BVFL
  • Analyst Count
  • CRBU 3
  • BVFL 0
  • Target Price
  • CRBU $6.67
  • BVFL N/A
  • AVG Volume (30 Days)
  • CRBU 1.3M
  • BVFL 25.0K
  • Earning Date
  • CRBU 11-05-2025
  • BVFL 10-17-2025
  • Dividend Yield
  • CRBU N/A
  • BVFL N/A
  • EPS Growth
  • CRBU N/A
  • BVFL 27.09
  • EPS
  • CRBU N/A
  • BVFL 1.07
  • Revenue
  • CRBU $9,121,000.00
  • BVFL $38,333,000.00
  • Revenue This Year
  • CRBU $8.06
  • BVFL N/A
  • Revenue Next Year
  • CRBU N/A
  • BVFL N/A
  • P/E Ratio
  • CRBU N/A
  • BVFL $14.35
  • Revenue Growth
  • CRBU N/A
  • BVFL 2.48
  • 52 Week Low
  • CRBU $0.66
  • BVFL $13.53
  • 52 Week High
  • CRBU $3.00
  • BVFL $18.19
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 64.30
  • BVFL 30.49
  • Support Level
  • CRBU $2.24
  • BVFL $15.47
  • Resistance Level
  • CRBU $2.39
  • BVFL $16.19
  • Average True Range (ATR)
  • CRBU 0.19
  • BVFL 0.31
  • MACD
  • CRBU 0.04
  • BVFL -0.14
  • Stochastic Oscillator
  • CRBU 94.75
  • BVFL 8.82

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About BVFL BV Financial Inc.

BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. The company offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, and business checking and certificates of deposit and IRA certificates of deposit. The Company's sources of revenue are derived from interest and dividends earned on loans and investment securities.

Share on Social Networks: